Tatsuro Fukuhara Selected Research

Tatsuro Fukuhara Research Topics

Disease

23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 07/2006
22	Neoplasms (Cancer) 12/2023 - 01/2005
5	Adenocarcinoma of Lung 11/2023 - 04/2008
5	Disease Progression 08/2023 - 01/2015
5	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2008
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2008
2	Carcinoma (Carcinomatosis) 12/2023 - 04/2022
2	Adenocarcinoma 01/2014 - 03/2008
1	Neuroendocrine Carcinoma 12/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Exanthema (Rash) 01/2019
1	Neutropenia 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 07/2018
1	Myasthenia Gravis 07/2018
1	Brain Neoplasms (Brain Tumor) 01/2015
1	Esophagitis 01/2015
1	Neuritis (Polyneuritis) 11/2014
1	Optic Neuritis (Retrobulbar Neuritis) 11/2014
1	Ovarian Neoplasms (Ovarian Cancer) 04/2014
1	Carcinogenesis 04/2014
1	Pneumonia (Pneumonitis) 08/2008
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2008
1	Meningeal Carcinomatosis 04/2008
1	Colonic Neoplasms (Colon Cancer) 04/2006
1	Melanoma (Melanoma, Malignant) 04/2006

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 08/2023 - 07/2006
9	Tyrosine Kinase InhibitorsIBA 08/2023 - 04/2008
4	NivolumabIBA 01/2024 - 07/2018
4	B7-H1 AntigenIBA 10/2023 - 03/2019
4	pembrolizumabIBA 08/2023 - 03/2019
4	Gefitinib (Iressa)FDA Link 10/2020 - 07/2006
3	IpilimumabIBA 01/2024 - 10/2023
3	osimertinibIBA 11/2023 - 08/2023
3	Bevacizumab (Avastin)FDA Link 04/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 03/2013
2	CarcinogensIBA 12/2018 - 04/2014
2	Anaplastic Lymphoma KinaseIBA 01/2015 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 08/2008
2	Urethane (Ethyl Carbamate)IBA 04/2014 - 05/2008
2	Secretory Leukocyte Peptidase InhibitorIBA 04/2014 - 05/2008
2	Epidermal Growth Factor (EGF)IBA 08/2008 - 04/2008
1	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2023
1	Culture MediaIBA 12/2023
1	nicotinate-nucleotide diphosphorylase (carboxylating)IBA 12/2023
1	nicotinamide riboside kinaseIBA 12/2023
1	NAD (NADH)IBA 12/2023
1	Nicotinamide PhosphoribosyltransferaseIBA 12/2023
1	Cell-Free Nucleic AcidsIBA 11/2023
1	PlatinumIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 04/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	menaquinone 6 FDA Link 11/2021
1	AlbuminsIBA 11/2021
1	Serum AlbuminIBA 11/2021
1	Pemetrexed (MTA)FDA Link 02/2021
1	UracilIBA 02/2021
1	TegafurIBA 02/2021
1	amrubicinIBA 01/2021
1	Monoclonal AntibodiesIBA 03/2019
1	LigandsIBA 03/2019
1	CarbonIBA 12/2018
1	Glucose (Dextrose)FDA LinkGeneric 12/2018
1	AfatinibIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 12/2018
1	CrizotinibIBA 01/2015
1	Retinaldehyde (Retinal)IBA 11/2014
1	AntibodiesIBA 11/2014
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2014
1	NF-kappa B (NF-kB)IBA 04/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2014
1	Surface-Active Agents (Surfactants)IBA 08/2008
1	LipopolysaccharidesIBA 08/2008
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 08/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2008
1	Codon (Codons)IBA 04/2008
1	Phosphotransferases (Kinase)IBA 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 07/2006
1	Chemokine CX3CL1IBA 04/2006
1	InterleukinsIBA 01/2005
1	CytokinesIBA 01/2005
1	Interleukin-4 (Interleukin 4)IBA 01/2005
1	VaccinesIBA 01/2005
1	Interleukin-12 (IL 12)IBA 01/2005

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2024 - 07/2006
8	Therapeutics 12/2023 - 05/2015
3	Immunotherapy 01/2024 - 01/2005
1	Diet Therapy (Therapy, Diet) 12/2023
1	Transplantation 12/2023
1	Aftercare (After-Treatment) 08/2023
1	Radiotherapy 02/2021
1	Chemoradiotherapy 02/2021
1	Cranial Irradiation 12/2015
1	Intranasal Administration 08/2008